JOHN SCHILTZ: Open Payments
NPI 1154533107 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 7 payments from 6 companies in 2025. Trend: 2023 $240 · 2024 $748 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $226 |
| E.R. Squibb & Sons, L.L.C. | 1 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $118 |
| Supernus Pharmaceuticals, Inc. | 1 | $100 |
Products named: FANAPT, COBENFY, CAPLYTA, REXULTI, Auvelity, Qelbree.
Industry payments across IN — which companies pay providers there.
